
Ikvarab 20 Tablet
Marketer
Ikvans Pharma
Salt Composition
Rabeprazole (20mg)
Overview Ikvarab 20 Tablet
Gastro-acid reducer Ikvarab 20mg tablets diminish stomach acid production. They treat stomach and intestinal conditions linked to excess acid, including acid reflux, peptic ulcers, and Zollinger-Ellison syndrome, offering symptom relief and aiding healing. Administer one tablet an hour before meals, ideally in the morning, following your doctor's prescribed dosage and schedule. Consistent use is crucial, even with rapid symptom improvement. Dietary adjustments, such as smaller, more frequent meals and avoiding caffeine, spicy foods, and fatty foods, can be beneficial. Common, usually mild, side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, and abdominal pain. Report persistent or bothersome side effects. Prolonged use (over a year) may elevate bone fracture risk, particularly at higher doses. Discuss bone health strategies, such as calcium and vitamin D supplementation, with your physician. Hypomagnesemia (low magnesium) can occur after three months or more of use, potentially causing fatigue, confusion, dizziness, muscle spasms, and irregular heartbeat. Your doctor may monitor your magnesium levels. Ikvarab 20mg tablets are not appropriate for everyone. Inform your doctor of severe liver disease, HIV medication use, prior allergic reactions to similar drugs, or pre-existing osteoporosis before starting treatment. Pregnant or breastfeeding individuals should seek medical counsel. Avoid alcohol, which stimulates excess stomach acid and exacerbates symptoms. Refrain from operating machinery or driving if experiencing dizziness or drowsiness.
Primary Ingredients of Ikvarab 20 Tablet
No text provided to rephrase.
Uses of Ikvarab 20 Tablet
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Ikvarab 20 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Ikvarab 20 Tablet whole; do not crush, chew, or break it. Administer on an empty stomach.
Common Side effects of Ikvarab 20 Tablet:
- Diarrhea
- Dizziness
- Flatulence
- Headache
- Nausea
- Sore throat
- Stomach pain
- Vomiting
How to use Ikvarab 20 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Ikvarab 20 Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Ikvarab 20 Tablet works:
Ikvarab 20mg tablets function as a proton pump inhibitor, decreasing stomach acid production to alleviate heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Using Ikvarab 20 Tablet with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Ikvarab 20 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Ikvarab 20 Tablet while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Ikvarab 20 Tablets might reduce alertness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely use Ikvarab 20 Tablet without any necessary dosage modifications.
LiverSAFE IF PRESCRIBED
Patients with liver disease can safely use Ikvarab 20 Tablet without requiring a change in dosage.
What if you forget to take Ikvarab 20 Tablet :
Should you forget to take your Ikvarab 20 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ikvarab 20 Tablet
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Actions | Gastric acid suppressants |
